Education
Dr. Lea Watson covers two drugs, Nuplazid and the new one approved by the FDA, Aducanumab. Followed by Dr. Sing Palat, CMD and new President of CMDA who discusses the use of oxygen with nocturnal hypoxemia in COPD.
Recording Date: 5/6/2021
Available Credit
- 0.25 CMD-Clinical
More Episodes
AMDA On-The-Hill | September 2022
2022-09-23
231
2022-09-23
231
Caring On-The-Go | August-September 2022
2022-08-31
343
2022-08-31
343
AMDA In-The-States | The Story Behind AB749 | July 2022
2022-07-25
388
2022-07-25
388
AMDA ON-THE-GO | Boosters, Vaccines, & More – COVID Update
2022-07-22
453
2022-07-22
453
AMDA In-The-States | The Why and How of Advocacy | June 2022
2022-07-11
443
2022-07-11
443
FMDA Journal Club | Achieving Quality Now
2022-06-27
524
2022-06-27
524
Caring On-The-Go | June-July 2022
2022-06-15
489
2022-06-15
489
FMDA Journal Club | Long COVID – Clinical Deep Dive
2022-06-15
454
2022-06-15
454
FMDA Journal Club | Cardiology Updates
2022-06-10
529
2022-06-10
529
AMDA On-The-Hill VOLUME XXV
2022-05-17
533
2022-05-17
533
Get this podcast on your
phone, FREE
Create your
podcast in
minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Integrate with iTunes and Google
store - Make money with your podcast
It is Free
